Reduced dose of subcutaneous cladribine induces identical response rates but decreased toxicity in pretreated chronic lymphocytic leukaemia. Swiss Group for Clinical Cancer Research (SAKK).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples